| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/30/2002 | US6426409 Nucleic acid molecules that bind prion proteins and processes for the production thereof |
| 07/30/2002 | US6426408 Plurality of nucleotide units with linking group |
| 07/30/2002 | US6426405 Therapeutic target for treatment of diseases associated with altered muscle activity of pain transmission; has properties of glycine transporter associated with strychnine sensitive glycine receptors--properties called ?sc6? activity |
| 07/30/2002 | US6426403 TRAF family molecules, polynucleotides encoding them, and antibodies against them |
| 07/30/2002 | US6426402 Respiratory system disorders; rheumatic diseases |
| 07/30/2002 | US6426336 Method for treating allergic lung disease |
| 07/30/2002 | US6426335 Vascular endothelial growth factor (VEGF) nucleic acid ligand complexes |
| 07/30/2002 | US6426334 Administering nucleotide sequence |
| 07/30/2002 | US6426224 Biosynthesis, mixing |
| 07/30/2002 | US6426221 Polynucleotide |
| 07/30/2002 | US6426220 Antisense modulation of calreticulin expression |
| 07/30/2002 | US6426218 Polypeptides; induction vascularization |
| 07/30/2002 | US6426217 MAGE-3 peptides presented by HLA class II molecules |
| 07/30/2002 | US6426216 Promoter segment in polypeptide |
| 07/30/2002 | US6426211 Xylanase derived from a Bacillus species, expression vectors for such xylanase and other proteins, host organisms therefor and use thereof |
| 07/30/2002 | US6426209 Mammalian heparanase protein |
| 07/30/2002 | US6426208 Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof |
| 07/30/2002 | US6426204 Method for detecting candida infection |
| 07/30/2002 | US6426199 Isolated, purified nucleic acid detecting or isolating mutant forms of the dna molecules. |
| 07/30/2002 | US6426198 Genes for Niemann-Pick type C disease |
| 07/30/2002 | US6426197 Isolated nucleotide sequence; genetic engineering |
| 07/30/2002 | US6426196 Alphavirus structural protein expression cassettes |
| 07/30/2002 | US6426189 Cellulose films for screening |
| 07/30/2002 | US6426188 Antisense modulation of phosphorylase kinase alpha 1 expression |
| 07/30/2002 | US6426185 Method of compiling a functional gene profile in a plant by transfecting a nucleic acid sequence of a donor plant into a different host plant in an anti-sense orientation |
| 07/30/2002 | US6426184 Making multimers such as dna or peptides in chemical reactor by solution-based photochemical reactions involving reagents generated in situ by irradiation |
| 07/30/2002 | US6426075 Genetic engineered polypeptide; killing cancer cells |
| 07/30/2002 | US6426071 Administering protein c |
| 07/30/2002 | US6426042 Methods and kits for improving retroviral-mediated gene transfer utilizing molecules, or mixture thereof, containing retroviral binding domains and target cell binding domains |
| 07/30/2002 | CA2369405A1 Har a polypeptides and nucleic acids, and related methods and uses thereof |
| 07/30/2002 | CA2266010C Thermal cycler for automatic performance of the polymerase chain reaction with close temperature control |
| 07/30/2002 | CA2252872C Fixed wireless terminals in network management method and apparatus |
| 07/30/2002 | CA2226293C Hcv ns3 protein fragments having helicase activity and improved solubility |
| 07/30/2002 | CA2084673C 16 kda surface protein of p.falciparum |
| 07/30/2002 | CA2083407C Microorganisms for the stabilization of plasmids |
| 07/29/2002 | CA2369249A1 A method for creating endothelial cell dysfunction in cell culture |
| 07/29/2002 | CA2366286A1 Sequences and methods for detection of hepatitis c virus |
| 07/26/2002 | CA2366238A1 Sequences and methods for detection of hepatitis b virus |
| 07/25/2002 | WO2002058323A2 Method for identifying modulators of bace |
| 07/25/2002 | WO2002057798A2 Sample processing device and method |
| 07/25/2002 | WO2002057792A2 Affinity selection-based screening of hydrophobic proteins |
| 07/25/2002 | WO2002057780A1 Biosensor with covalently attached membrane-spanning proteins |
| 07/25/2002 | WO2002057778A1 Screening assay for cotranslational translocation interfering compounds |
| 07/25/2002 | WO2002057664A2 Bacillus thuringiensis insecticidal proteins |
| 07/25/2002 | WO2002057499A2 Mdr1 variants and methods for their use |
| 07/25/2002 | WO2002057497A2 High through-put cloning of protooncogenes |
| 07/25/2002 | WO2002057495A2 A modeling framework for predicting the number, type, and distribution of crossovers in directed evolution experiments |
| 07/25/2002 | WO2002057492A1 Methods and compositions for detecting polynucleotide duplex damage |
| 07/25/2002 | WO2002057491A2 Direct multiplex characterization of genomic dna |
| 07/25/2002 | WO2002057489A2 Method of determining a chemotherapeutic regimen based on ercc1 and ts expression |
| 07/25/2002 | WO2002057487A2 Suppression of non-specific nucleic acid amplification |
| 07/25/2002 | WO2002057486A2 Dual fidelity erca detection systems |
| 07/25/2002 | WO2002057484A2 Method and test system for identifying substances which protect nerve cells |
| 07/25/2002 | WO2002057483A2 Method of identifying modulators of nogo-functions |
| 07/25/2002 | WO2002057480A2 Cell-proliferative disorder treatments using cre decoy oligomers, bcl-2 antisense and hybrid oligomers |
| 07/25/2002 | WO2002057479A2 Primers and methods for the detection and discrimination of nucleic acids |
| 07/25/2002 | WO2002057478A1 Methods and compositions for extracting proteins from cells |
| 07/25/2002 | WO2002057476A2 Methods and microorganisms for the production of 3-(2-hydroxy-3-methyl-butyrylamino)-propionic acid (hmbpa) |
| 07/25/2002 | WO2002057474A2 Processes for enhanced production of pantothenate |
| 07/25/2002 | WO2002057473A1 Method for inhibiting vegf and epo gene expression by quercetin |
| 07/25/2002 | WO2002057472A1 Selectable marker for genetically engineered cells and tissues |
| 07/25/2002 | WO2002057471A2 Maize chloroplast aldolase promoter compositions and methods for use thereof |
| 07/25/2002 | WO2002057470A1 Isolation and characterisation of an anther-specific promoter (cofs) in cotton |
| 07/25/2002 | WO2002057469A2 Modulating developmental transitions in plants |
| 07/25/2002 | WO2002057468A2 Method for secretory production of glycoprotein having human-type sugar chain using plant cell |
| 07/25/2002 | WO2002057467A2 Use of umbravirus in protection against post-transcriptional gene silencing |
| 07/25/2002 | WO2002057466A2 Processes and vectors for plastid transformation of higher plants |
| 07/25/2002 | WO2002057465A2 Method for producing polyunsaturated fatty acids, novel biosynthesis genes and novel plant expression constructs |
| 07/25/2002 | WO2002057464A2 Method for the expression of biosynthetic genes in plant seeds using multiple expression constructs |
| 07/25/2002 | WO2002057463A2 Swap/counter selection; a rapid cloning method |
| 07/25/2002 | WO2002057462A1 Vector for introducing molecules in eukaryotic cells and molecules vectorized by same |
| 07/25/2002 | WO2002057461A2 Regulation of human adam-ts-like zinc metalloprotease |
| 07/25/2002 | WO2002057460A2 Polynucleotides encoding human phosphatases |
| 07/25/2002 | WO2002057459A2 Dna sequence of the enzyme phospholipase a1 of ciliate tetrahymena, and the use of the same |
| 07/25/2002 | WO2002057458A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 07/25/2002 | WO2002057457A2 Human proteins 55562 and 21617, and methods of use thereof |
| 07/25/2002 | WO2002057456A2 Regulators of fungal gene expression |
| 07/25/2002 | WO2002057455A2 Nucleic acid sequences from drosophila melanogaster that encode proteins essential for larval viability and uses thereof |
| 07/25/2002 | WO2002057454A2 Receptors and membrane-associated proteins |
| 07/25/2002 | WO2002057453A2 Polypetides and nucleic acids encoding same |
| 07/25/2002 | WO2002057452A2 Human proteins, polynucleotides encoding them and methods of using the same |
| 07/25/2002 | WO2002057451A1 Humanized polynucleotide sequence encoding renilla mulleri green fluorescent protein |
| 07/25/2002 | WO2002057450A2 Proteins and nucleic acids encoding same |
| 07/25/2002 | WO2002057449A1 Novel gene tifa |
| 07/25/2002 | WO2002057448A1 Novel peptides and activities thereof |
| 07/25/2002 | WO2002057447A2 Methods and reagents for amplification and manipulation of vector and target nucleic acid sequences |
| 07/25/2002 | WO2002057446A2 Method for treating biomass for producing cell lysate containing plasmid dna |
| 07/25/2002 | WO2002057445A1 Single-domain brain-targeting antibody fragments derived from llama antibodies |
| 07/25/2002 | WO2002057442A1 Gene disrupted yeast |
| 07/25/2002 | WO2002057439A2 Plant transcription factors |
| 07/25/2002 | WO2002057438A2 Transgenic mice containing disruptions of the lxrb retinoid x receptor interacting protein gene |
| 07/25/2002 | WO2002057437A2 Generation of human cytomegalovirus yeast artificial chromosome recombinants |
| 07/25/2002 | WO2002057436A2 Red blood cell from a transgenic animal as vehicle for polypeptide delivery |
| 07/25/2002 | WO2002057435A2 Bifunctional fusion proteins with glucocerebrosidase activity |
| 07/25/2002 | WO2002057433A2 Homeodomain-interacting protein kinases and the use of the same for influencing cell division and cell proliferation |
| 07/25/2002 | WO2002057429A2 A method for producing a population of homozygous stem cells having a pre-selected immunophenotype and/or genotype |
| 07/25/2002 | WO2002057427A2 Mammalian tumor susceptibility gene products and their uses |
| 07/25/2002 | WO2002057424A2 Nucleic acid delivery formulations |
| 07/25/2002 | WO2002057423A2 Isolating cells expressing secreted proteins |
| 07/25/2002 | WO2002057418A2 Methods of producing polyketide synthase mutants and compositions and uses thereof |